Etsuko Toda

Title: Etsuko Toda: Innovator in Cancer Prognosis and Treatment

Introduction

Etsuko Toda is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical science, particularly in cancer prognosis and treatment. With a total of 2 patents, her work focuses on innovative methods that enhance patient care and treatment outcomes.

Latest Patents

Etsuko Toda's latest patents include a method for predicting the prognosis of patients with cancer or inflammatory diseases. This novel approach involves measuring the expression level of the FROUNT gene in samples collected from patients. Since FROUNT is identified as a poor prognostic factor, lower expression levels indicate a better prognosis. Additionally, her patent addresses the measurement of the CC chemokine receptor/ligand gene, where higher expression levels correlate with improved patient outcomes. Another significant patent involves an agent for controlling cells in the cancer microenvironment or inflammatory microenvironment. This agent comprises components such as disulfiram and its derivatives, aimed at inhibiting harmful interactions and enhancing the efficacy of anticancer drugs.

Career Highlights

Etsuko Toda is affiliated with the Tokyo University of Science Foundation, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient prognoses through innovative methodologies.

Collaborations

Etsuko collaborates with notable colleagues, including Yuya Terashima and Kouji Matsushima, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Etsuko Toda's contributions to cancer prognosis and treatment exemplify the vital role of innovation in healthcare. Her patents reflect a dedication to improving patient outcomes and advancing medical research.